Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593

MLA

Asher L. Brandt, et al. “Pharmacological Evaluation of Enantiomerically Separated Positive Allosteric Modulators of Cannabinoid 1 Receptor, GAT591 and GAT593.” Frontiers in Pharmacology, vol. 13, Oct. 2022. EBSCOhost, https://doi.org/10.3389/fphar.2022.919605.

APA

Asher L. Brandt, Sumanta Garai, Ayat Zagzoog, Dow P. Hurst, Lesley A. Stevenson, Roger G. Pertwee, Gregory H. Imler, Patricia H. Reggio, Ganesh A. Thakur, & Robert B. Laprairie. (2022). Pharmacological evaluation of enantiomerically separated positive allosteric modulators of cannabinoid 1 receptor, GAT591 and GAT593. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.919605

Chicago

Asher L. Brandt, Sumanta Garai, Ayat Zagzoog, Dow P. Hurst, Lesley A. Stevenson, Roger G. Pertwee, Gregory H. Imler, Patricia H. Reggio, Ganesh A. Thakur, and Robert B. Laprairie. 2022. “Pharmacological Evaluation of Enantiomerically Separated Positive Allosteric Modulators of Cannabinoid 1 Receptor, GAT591 and GAT593.” Frontiers in Pharmacology 13 (October). doi:10.3389/fphar.2022.919605.